Page last updated: 2024-09-02

opc 21268 and Body Weight

opc 21268 has been researched along with Body Weight in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldred, KL; Burrell, LM; Hutchins, AM; Johnston, CI; Phillips, PA; Risvanis, J1
Kanno, Y; Okada, H; Saruta, T; Suzuki, H2
Arakawa, K; Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Oka, K; Saruta, T; Suzuki, H; Yamamura, Y1
Hashimoto, M; Makino, H; Mimura, Y; Ogura, T; Oishi, T; Otsuka, F; Yamauchi, T1
Burrell, LM; Fraser, TB; Li, M; Turner, SW; Wen, C; Whitworth, JA1

Other Studies

6 other study(ies) available for opc 21268 and Body Weight

ArticleYear
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:5

    Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Female; Hypertension; Male; Piperidines; Quinolones; Ramipril; Rats; Rats, Inbred SHR

1995
Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1995, Volume: 17, Issue:3

    Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Body Weight; Desoxycorticosterone; Hypertension; Male; Piperidines; Quinolones; Random Allocation; Rats; Rats, Wistar; Sodium Chloride

1995
Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney; Male; Nephrectomy; Nephrosclerosis; Piperidines; Proteinuria; Quinolones; Rats; Rats, Inbred SHR

1995
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
    The American journal of physiology, 1994, Volume: 267, Issue:6 Pt 2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Capillary Resistance; Cardiac Output; Cardiac Pacing, Artificial; Diuresis; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Osmolar Concentration; Piperidines; Potassium; Quinolones; Renin; Sodium

1994
Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats.
    Regulatory peptides, 1997, Oct-31, Volume: 72, Issue:2-3

    Topics: Acetylglucosaminidase; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Growth Substances; Heart Rate; Hypertension; Kidney Glomerulus; Organ Size; Piperidines; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Proliferating Cell Nuclear Antigen; Proteinuria; Quinolones; Random Allocation; Rats; Rats, Inbred SHR; RNA, Messenger; Sodium; Transforming Growth Factor beta; Urine

1997
Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat.
    Clinical and experimental pharmacology & physiology, 2000, Volume: 27, Issue:11

    Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Blood Pressure; Body Weight; Hematocrit; Hypertension; Male; Organ Size; Osmolar Concentration; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Urodynamics

2000